Journey Medical NASDAQ DERM Reports 21 Revenue Growth in Q1 2026 Remains Unprofitable Chinas Tariff Offer to Africa Strategic Interests Optics and Practical Constraints Nadella Testifies Musk Never Voiced Concerns Over Microsofts OpenAI Investment During Trial CLARITY Act Faces Over 100 Amendments as Crypto Legislation Nears Vote